CHIKUNGUNYA
Clinical trials for CHIKUNGUNYA explained in plain language.
Never miss a new study
Get alerted when new CHIKUNGUNYA trials appear
Sign up with your email to follow new studies for CHIKUNGUNYA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chikungunya vaccine enters first human tests
⭐️ VACCINE ⭐️ Not yet recruitingThis early-phase trial tests a new vaccine called PepGNP-ChikV, designed to protect against chikungunya virus. About 40 healthy adults aged 18 to 60 will receive two shots, 42 days apart, and be monitored for safety and immune response for a year. The vaccine uses tiny nanopartic…
Matched conditions: CHIKUNGUNYA
Phase: EARLY_PHASE1 • Sponsor: Gylden Pharma Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 07:03 UTC
-
Two-for-One vaccine shot? new study tests combined dengue and chikungunya protection
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests whether giving two live vaccines—one for dengue and one for chikungunya—at the same time is as safe and effective as giving them separately. About 900 adults aged 18 to 59 who have never been exposed to either virus will take part. The goal is to see if a single …
Matched conditions: CHIKUNGUNYA
Phase: PHASE3 • Sponsor: Butantan Institute • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 06:50 UTC